Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual bNAbs for viral control in early HIV infection
NCT04319367Phase 2Recruiting
- Sponsor
- Imperial College London
- Start
- May 2021
- Primary completion
- Jul 2027
- Modality
- Anti-infectious Disease mAbs
- Countries
- 2
01
Overview
A Phase 2 trial of Teropavimab, zinlirvimab in human immunodeficiency virus infection (HIV), sponsored by Imperial College London. Started May 2021; status: recruiting.
02
Drugs
Teropavimabzinlirvimab
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04319367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04319367.